The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a exciting advance. Unlike subcutaneous injections, this approach offers a more convenient way to deliver GLP-1 medications. These transdermal systems steadily release the drug through the epidermis offering a stable dose of the therapeutic… Read More